Soares Miranda, L.; Sousa, M.J.; Martins Braga, M.; Couto, M.; Vieira Fernandes, I.; Abreu, F.; Eiriz, I.; Lopes Fernandes, C.; Fonseca Marques, A.; Marques, M.T.;
et al. Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population. Cancers 2025, 17, 1911.
https://doi.org/10.3390/cancers17121911
AMA Style
Soares Miranda L, Sousa MJ, Martins Braga M, Couto M, Vieira Fernandes I, Abreu F, Eiriz I, Lopes Fernandes C, Fonseca Marques A, Marques MT,
et al. Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population. Cancers. 2025; 17(12):1911.
https://doi.org/10.3390/cancers17121911
Chicago/Turabian Style
Soares Miranda, LuÃsa, Maria João Sousa, Miguel Martins Braga, Marisa Couto, Isabel Vieira Fernandes, Francisca Abreu, Inês Eiriz, Catarina Lopes Fernandes, Alice Fonseca Marques, Maria Teresa Marques,
and et al. 2025. "Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population" Cancers 17, no. 12: 1911.
https://doi.org/10.3390/cancers17121911
APA Style
Soares Miranda, L., Sousa, M. J., Martins Braga, M., Couto, M., Vieira Fernandes, I., Abreu, F., Eiriz, I., Lopes Fernandes, C., Fonseca Marques, A., Marques, M. T., Romão, R., Gonçalves, F., Simões, J., & Araújo, A.
(2025). Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population. Cancers, 17(12), 1911.
https://doi.org/10.3390/cancers17121911
